World Orphan Drug Congress USA 2024 Will Take Place on April 23 – 25 in Boston, Mass.

Boston, Mass. – The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.

Highlighted agenda topics include:

  • Transformative policies and strategies for orphan drug accessibility
  • NIH as your technology development and commercialization partner
  • Current best practices for diversity in clinical trials
  • How to successfully achieve reimbursement in rare diseases: From inception to submission
  • Strategies to save time and cost in rare disease drug development
  • Access for rare disease patients in Europe and beyond
  • Commercialization in rare disease
  • Understanding the implications of state policies on patient access
  • Using biomarkers to accelerate development of disease modifying therapies for rare disease
  • Industry perspectives: Partnering in the rare disease space

For further information about the congress, including registration and abstract submission, please click here.

 

Congress details

When:  April 23-25, 2024

Venue:  Boston Convention and Exhibition Center – 415 Summer Street, Boston, MA 02210